BNT-162A1 EXPRESSED PREPROTEIN
UNII NL03OD9SS5

Substance Identification & Data

This profile provides standardized clinical and technical data for Bnt-162a1 Expressed Preprotein, uniquely identified by the FDA Unique Ingredient Identifier (UNII) NL03OD9SS5.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
NL03OD9SS5
CAS Registry Number
N/A
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
BNT-162A1 EXPRESSED PREPROTEIN
Official standardized name for this substance within the FDA UNII nomenclature system.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Bnt-162a1 Expressed Preprotein. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

BNT-162A1 EXPRESSED PREPROTEIN
SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 SPIKE GLYCOPROTEIN S1S2 SECRETORY SIGNAL PEPTIDE PLUS RECEPTOR-BINDING DOMAIN FUSION PROTEIN WITH T4 FIBRITIN FOLDON DOMAIN-SPECIFYING

External Clinical & Regulatory Resources

NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record